Global Pet Pharmaceuticals Market Growth 2023-2029

Global Pet Pharmaceuticals Market Growth 2023-2029

Pet pharmaceutical refers specifically to medicines given to pets.
In terms of the purpose of use, pet drugs are mainly used by dogs and cats. Through drug prevention and treatment of pet diseases, the cure rate of pet diseases can be improved, the physical and mental health of pets can be guaranteed, and the quality of life of pets can be improved.
In terms of clinical significance, the application of pet drugs can provide clinical data for the research and development of new pet drugs, and promote the replacement and upgrading of new pet drugs.
LPI (LP Information)' newest research report, the “Pet Pharmaceuticals Industry Forecast” looks at past sales and reviews total world Pet Pharmaceuticals sales in 2022, providing a comprehensive analysis by region and market sector of projected Pet Pharmaceuticals sales for 2023 through 2029. With Pet Pharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Pharmaceuticals industry.
This Insight Report provides a comprehensive analysis of the global Pet Pharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Pharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pet Pharmaceuticals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Pharmaceuticals and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Pharmaceuticals.
The global Pet Pharmaceuticals market size is projected to grow from US$ 13960 million in 2022 to US$ 22800 million in 2029; it is expected to grow at a CAGR of 22800 from 2023 to 2029.
The major players in global Pet Pharmaceuticals market include Zoetis, Boehringer Ingelheim, Merck, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Antiparasitic is the main type, with a share about 30%. Prevention is the main application, which holds a share about 80%.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Pharmaceuticals market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Antiparasitic
Biological Products
Antibacterial
Others
Segmentation by application
Prevention
Treatment
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Chopperlvya Animal Health
CAHIC

Key Questions Addressed in this Report
What is the 10-year outlook for the global Pet Pharmaceuticals market?
What factors are driving Pet Pharmaceuticals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet Pharmaceuticals market opportunities vary by end market size?
How does Pet Pharmaceuticals break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.